Public Launch Date definition

Public Launch Date means the date on which the Company first makes video distribution services publicly available to Subscribers on a paying basis.
Sample 1Sample 2
Public Launch Date means the date on which تار¹aا. (dotEmarat) Arabic Domain Names are available on a First-Come, First Served basis;
Sample 1
Public Launch Date means the date on which the Co-Branded Service is launched to the general Internet public on xxxxxxxxxxx.xxx.
Sample 1

Examples of Public Launch Date in a sentence

  • At any time prior to the Public Launch Date, TMP shall have the right to (i) consult with MyBiz as often as may be necessary and reasonable regarding the design of, and development schedule for, the Co-Branded Service; and (ii) provide creative guidance to MyBiz and assist in the editorial review of the Co-Branded Service.

  • It is the intention of the parties for the Public Launch Date to occur within 21 business days from the date of this Agreement.

  • In addition, AAV has a reported incidence of 4,000 and 7,500 new patients per year in the United States and Europe, respectively.

  • If you do not desire to continue using the Site or its Services after the Public Launch Date, you may contact eVisit to delete your account in accordance with the terms and conditions governing deletion of personal information set forth in eVisit’s Privacy Policy.

  • If User does desires to continue using the Haystack Platform after the Public Launch Date, User must sign up for a commercial account.

Related to Public Launch Date

  • Launch Date has the meaning specified therefor in Section 2.02(b) of this Agreement.

  • Launch means the intentional ignition of the first-stage motor(s) of the Launch Vehicle intended to place or try to place a Launch Vehicle (which may or may not include any Transfer Vehicle, Payload or crew) from Earth:

  • Public library means a library that is lawfully established for free public purposes by 1 or more counties, cities, townships, villages, school districts, or other local governments or a combination thereof, or by a public or local act, the entire interests of which belong to the general public. Public library does not include a special library such as a professional, technical, or school library.

  • Commercial Launch means the initial First Commercial Sale of a Product in the Territory.

  • Massive Multiauthor Collaboration Site (or “MMC Site”) means any World Wide Web server that publishes copyrightable works and also provides prominent facilities for anybody to edit those works. A public wiki that anybody can edit is an example of such a server. A “Massive Multiauthor Collaboration” (or “MMC”) contained in the site means any set of copyrightable works thus published on the MMC site.

  • Public lands ’ means (A) all lands under the cus- tody and control of the Secretary of the Interior and the Secretary of Agriculture, except Indian lands, (B) lands under the custody and control of the Tennessee Valley Authority that are situated in western Ken- tucky and Tennessee and are designated as ‘‘Land Be- tween the Lakes,’’ and (C) lands under the custody and control of the Secretary of Defense;

  • Programme Date means the date of this Base Prospectus.

  • Public land means land owned by the federal government, the state, or political subdivisions of the state and land acquired or developed for public recreation pursuant to section 321I.8.

  • Regulatory Exclusivity Period means, with respect to each Licensed Product in any country in the Territory, a period of exclusivity (other than Patent exclusivity) granted or afforded by Applicable Law or by a Regulatory Authority in such country that confers exclusive marketing rights with respect to such Licensed Product in such country or prevents another Person from using or otherwise relying on any data supporting the approval of the Drug Approval Application for such Licensed Product to support an application for regulatory approval of another product for any indication without the prior written consent of the Drug Approval Application holder.

  • Phase I Clinical Study means a human clinical study of a product, the principal purpose of which is a preliminary determination of safety in healthy individuals or patients, as described in 21 C.F.R. 312.21(a).

  • Phase I Clinical Trial means a human clinical trial that is intended to initially evaluate the safety and/or pharmacological effect of a Product in subjects or that would otherwise satisfy requirements of 21 C.F.R. 312.21(a), or its foreign equivalent.

  • Technically Feasible refers solely to technical or operational concerns, rather than economic, space, or site considerations.

  • Core Curriculum Content Standards means the New Jersey Student Learning Standards.

  • Phase III Clinical Study means a trial involving administration of a Compound to sufficient numbers of human patients with the goal of establishing that the Compound is safe and efficacious for its intended use, to define warnings, precautions and adverse reactions that are associated with the drug or label expansion of such Compound, and to be considered as a pivotal study for submission of an NDA.

  • Licensed Program means the executable processing programs of licensed information, which is composed of various modules in the Licensed Software package provided by the Licensor.

  • Video programming means programming provided by, or generally considered comparable to programming provided by, a television broadcast station.

  • Clinical nurse specialist means a registered nurse with relevant post-basic qualifications and 12 months’ experience working in the clinical area of his/her specified post-basic qualification, or a minimum of four years’ post-basic registration experience, including three years’ experience in the relevant specialist field and who satisfies the local criteria.

  • Phase III Clinical Trials means a Clinical Trial for the Product on sufficient numbers of patients to generate safety and efficacy data to support Regulatory Approval in the proposed therapeutic indication, conducted in accordance with current good clinical practices and in accordance with a protocol that has been reviewed by the FDA and reflects any comments or concerns raised by the same.

  • Pre-Licensed Therapist means an individual who has obtained a Master’s Degree in Social Work or Marriage and Family Therapy and is registered with the BBS as an Associate CSW or MFT Intern acquiring hours for licensing. An individual’s registration is subject to regulations adopted by the BBS.

  • Phase III Clinical Trial means a human clinical trial of a product, the design of which is acknowledged by the FDA to be sufficient for such clinical trial to satisfy the requirements of 21 C.F.R. 312.21(c) (as amended or any replacement thereof), or a similar human clinical trial prescribed by the Regulatory Authority in a country other than the United States, the design of which is acknowledged by such Regulatory Authority to be sufficient for such clinical trial to satisfy the requirements of a pivotal efficacy and safety clinical trial.

  • Regulatory Information Service means a regulatory information service as defined in the Takeover Rules.

  • Supported Web Browser means the current release from time to time of Microsoft Edge, Mozilla Firefox, Google Chrome or Apple Safari, or any other web browser that the Provider agrees in writing shall be supported;

  • Phase II Clinical Study means a human clinical study of a product initiated to determine the safety and efficacy in the target patient population, as described 21 C.F.R. 312.21(b).

  • Publication Date means an Ordinary Publication Date or an Extraordinary Publication Date, as the case may be.

  • Licensed Nurse means an Oregon licensed practical or registered nurse.

  • Phase 3 Clinical Trial means a pivotal clinical trial in humans performed to gain evidence with statistical significance of the efficacy of a product in a target population, and to obtain expanded evidence of safety for such product that is needed to evaluate the overall benefit-risk relationship of such product, to form the basis for approval of an NDA and to provide an adequate basis for physician labeling, as described in 21 C.F.R. § 312.21(c) or the corresponding regulation in jurisdictions other than the United States.